Pharmaceutical Care Management Association | PCMA

How PBMs Work

How PBMs Work

PBMs Work At the Center of Health and Savings

‍Pharmacy benefit companies are working every day on behalf of employers and health plans to secure savings on prescription drugs, enable better health outcomes for patients, and support access to quality prescription drug coverage for more than 275 million patients.

Stop Big Pharma’s $32 Billion Money Grab

Big Pharma already games the system to block competition and keep drug prices high. Now, Big Pharma is pushing a self-serving “delinking” agenda, which would give Big Pharma a $32 BILLION windfall at the expense of hardworking Americans, including seniors.

LATEST NEWS:

New Survey Finds Employers Overwhelmingly Satisfied With PBMs’ Transparency, Flexibility And Savings

LATEST NEWS

(Washington, D.C.) — PCMA today released the results of a new survey of nearly 700 employers across the country examining the experiences and perceptions of employers working with pharmacy benefit managers (PBMs) on prescription drug coverage for their employees. The survey was commissioned by PCMA and conducted by nonpartisan, objective research organization NORC at the University of Chicago.

PCMA Events

Business Forum 2025
March 10 & 11

Arizona Biltmore
Phoenix, AZ

See Past Events >

PCMA Industry Relations Hub

For detailed event information, photos, videos, and more, head to the PCMA Industry Relations Hub.

Thought Leadership

Resources on Diversifying Your Organization and Opportunities for Diverse Individuals

DEI RESOURCES

PCMA is committed to working toward a more equitable health care system. One key component to advancing health care equity and reducing health disparities is advancing culturally competent care.

PBMs and Pharmacies

PBMs AND PHARMACIES

Each year, PBMs save patients and the U.S. health care system an average of $1,040 per person. Without PBMs, employers and health plans would be forced to go it alone on pharmacy benefits, which would result in significantly higher drug costs for patients.

FEATURED INFOGRAPHIC

GLP-1s for Weight Loss and How PBMs Are Rising to the Challenges

Semaglutide, liraglutide, and tirzepatide are all glucagon-like peptide-1 (GLP-1)1 agonists initially approved by the U.S Food and Drug Administration (FDA) for type 2 diabetes and more recently for weight management.

Health Equity

HEALTH EQUITY

Pharmacy benefit companies, in collaboration with plan sponsors, clinicians, and government programs, have a long history of working to advance health equity; however, the severity of the health disparities revealed during the COVID-19 pandemic spurred the Pharmacy Benefit Managers (PBMs) industry to develop a more unified response.

Pharmaceutical Care
Management Association

325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700

©2024 PCMA. All Rights Reserved.